The line-up consists of supplements to meet the health needs to patients taking GLP-1 medications for weight loss.

A new paper by the Institute for Clinical and Economic Review (ICER) looks at the cost-effectiveness versus affordability ...

A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had ...

Employer health plans brace for ongoing soaring costs as weight-loss drug utilization rises. What trends are coming down the ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

GLP-1 drugs are making waves in the world of weight loss and health management, but what exactly are they? Allison Debussy, an APRN with Baptist Health Weight L ...

As discussions unfold, Kennedy seeks to balance drug accessibility with concerns about the long-term costs of providing GLP-1 ...

GLP-1 Drug Use For Weight Loss Has Soared, Costing Billions By Dennis Thompson HealthDay Reporter TUESDAY, April 1, 2025 (HealthDay News) -- The number of Americans taking cutting-edge weight-loss ...

For decades, Americans have sought a “miracle drug” to combat obesity, and the emergence of GLP-1 agonists seems to fit the bill. The rapid public uptake of these medications for their ...

The number of people without diabetes taking a GLP-1 drug more than tripled between 2018 and 2022 in the United States, researchers reported Monday in the Annals of Internal Medicine. Spending on ...

The family of medications called GLP-1 receptor agonists includes drugs like Wegovy, Zepbound, Ozempic, Mounjaro and Victoza. They were originally developed to treat type 2 diabetes, which happens ...